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Abstract
Members of the genus Yatapoxvirus, which include Tanapox virus (TPV) and Yaba monkey tumor virus, infect primates including humans. Two
strains of TPV isolated 50 years apart from patients infected from the equatorial region of Africa have been sequenced. The original isolate from
a human case in the Tana River Valley, Kenya, in 1957 (TPV-Kenya) and an isolate from an infected traveler in the Republic of Congo in 2004
(TPV-RoC). Although isolated 50 years apart the genomes were highly conserved. The genomes differed at only 35 of 144,565 nucleotide positions
(99.98% identical). We predict that TPV-RoC encodes 155 ORFs, however a single transversion (at nucleotide 10241) in TPV-Kenya resulted
in the coding capacity for two predicted ORFs (11.1L and 11.2L) in comparison to a single ORF (11L) in TPV-RoC. The genomes of TPV are
A + T rich (73%) and 96% of the sequence encodes predicted ORFs. Comparative genomic analysis identified several features shared with other
chordopoxviruses. A conserved sequence within the terminal inverted repeat region that is also present in the other members of the Yatapoxviruses
as well as members of the Capripoxviruses, Swinepox virus and an unclassified Deerpox virus suggests the existence of a conserved near-terminal
sequence secondary structure. Two previously unidentified gene families were annotated that are represented by ORF TPV28L, which matched
homologues in certain other chordopoxviruses, and TPV42.5L, which is highly conserved among currently reported chordopoxvirus sequences.
© 2007 Elsevier B.V. All rights reserved.
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1. Introduction
Poxviruses constitute two sub-families, Chordopoxvirinae
and Entomopoxvirinae, which infect a wide range of ver-
 Disclaimer: The findings and conclusions in this report are those of the
authors and do not necessarily represent the views of the funding agencies. Use
of trade names or commercial sources is for identification only and does not
imply endorsement by the funding agencies.
∗ Corresponding author. Present address: University of Florida, 1600 SW
Archer Road, ARB Room R4-295, P.O. Box 100332, Gainesville, FL 32610,
USA. Tel.: +1 352 273 6852; fax: +1 352 273 6849.
E-mail address: grantmcf@ufl.edu (G. McFadden).
tebrate and insect hosts, respectively (Buller et al., 2005).
Characteristic features of poxviruses include a cytoplasmic
life cycle, a large virion size and large genome compared
to other viruses (Moss, 2007). Poxviruses contain a linear,
double-stranded DNA genome with palindromic, covalently-
closed ends. Sequenced poxvirus genomes vary from ∼134 to
∼360 kbp in length and 130 to 328 open reading frames (ORFs)
can be predicted from the sequences. At the ends of poxvirus
DNA genomes are mirror image terminal inverted repeat (TIR)
regions, however, among different strains the lengths of the
TIR regions vary from a few hundred nucleotides, such as in
Variola virus (VARV), to approximately 12 kbp, such as in
Shope fibroma virus (SHFV). In general, the chordopoxvirus
0168-1702/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.virusres.2007.05.001
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genome is organized so that the essential housekeeping genes,
including those required for transcription, replication and mor-
phogenesis, are located within the central region of the genome.
Genes nearer to the DNA ends are generally more variable
and encode for a wide variety of functions, including genes
dedicated to ensure virus replication within the host by mod-
ulating the host innate and adaptive immune response (Seet et
al., 2003).
The genomic DNA sequences of over 100 different poxvirus
strains have been determined. The particular poxvirus sequences
used in the present study are listed in Table 1. All of the
sequences used are available through GenBank and two curated
poxvirus sites—www.poxvirus.org/ and www.biovirus.org/.
There are two species in the genus Yatapoxvirus: Yaba
monkey tumor virus (YMTV) and Tanapox virus (TPV). Both
species have caused human infection. A previously sequenced
poxvirus, Yaba-like disease virus (YLDV) (Lee et al., 2001),
is a TPV from an infected non-human primate (Brunetti et
al., 2003; Espana et al., 1971; Esposito and Fenner, 2001;
McNulty et al., 1968). TPV and YLDV are suspected to be
transmitted by arthropod vectors and both produce a similar
rash illness, fever with prodromal symptoms that is followed
by the development of few nodular skin lesions (Downie
and Espana, 1972; Damon, 2007; Knight et al., 1989). In
contrast, YMTV produces a very distinct disease, primarily
in non-human primates, which is characterized by epidermal
histiocytomas of the head and limbs (Downie and Espana,
1972; Knight et al., 1989). The observed biological differences
between YMTV and YLDV are likely explained by the 82%
nucleotide identity and an approximately 10 kbp deletion from
YMTV compared to YLDV (Brunetti et al., 2003; Downie and
Espana, 1972; Espana et al., 1971; Knight et al., 1989; Lee et al.,
2001).
A previous study, in which the genome of YMTV was
sequenced, examined the conservation of certain gene fami-
lies that were found to be below the usual 50 codon cutoff
(Brunetti et al., 2003). To further this research, two isolates of
TPV were sequenced; one is the first isolate from a 1957 human
outbreak of TPV in the Tana River valley in Kenya (TPV-Kenya)
and the other was isolated from an infected college student
traveling in the Congo Basin in the Republic of Congo (TPV-
RoC) (Dhar et al., 2004). The current study is a comparative
genomic analysis of these two isolates of TPV that are from dis-
crete geographic regions of Africa and isolated 50 years apart.
Table 1
Summary information of poxvirus sequences used in this study
Genus Virus Strain Virus short form Genome size (bp) Accession number Reference
Yatapox
Tanapox virus RoC TPV-RoC 144553 EF420157 This study
Tanapox virus Kenya TPV-Kenya 144565 EF420156 This study
Yaba-like disease virus YLDV 144575 NC 002642 Lee et al. (2001)
Yaba monkey tumor virus Roswell Park-Yohn YMTV 134721 NC 005179 Brunetti et al. (2003)
Capripox
Goatpox virus Pellor GTPV 149599 NC 004003 Tulman et al. (2002)
Lumpy skin disease virus Neethling 2490 LSDV 150773 NC 003027 Tulman et al. (2001)
Sheeppox virus A SHPV 150057 AY077833 Tulman et al. (2002)
Suipox Swinepox virus Nebraska 17077-99 SWPV 146454 NC 003389 Afonso et al. (2002)a
Leporipox Myxoma virus Lausanne MYXV 161773 NC 001132 Cameron et al. (1999)Shope fibroma virus Kasza SHFV 159857 NC 001266 Willer et al. (1999)
Molluscipox Molluscum contagiosum virus Subtype 1 MOCV 190289 NC 001731 Senkevich et al. (1996)
Orthopox
Camelpox virus CMS CMPV 202205 AY009089 Gubser and Smith (2002)
Cowpox virus Brighton Red CPXV 224499 C 003663
Ectromelia virus Moscow ECTV 209771 NC 004105
Horsepox virus MNR-76 HSPV 212633 DQ792504 Tulman et al. (2006)
Monkeypox virus Zaire MPXV 196858 NC 003310 Shchelkunov et al. (2001)
Raccoonpox virus RCNV NDa M23018
Taterapox virus Dahomey 1968 TATV 198050 NC 008291
Vaccinia virus Western Reserve VACV 194711 NC 006998
Variola virus India 1964 7125 Vellor VARV 186127 DQ437586 Esposito et al. (2006)
Avipox Canarypox virus ATCC VR111 CNPV 359853 NC 005309 Tulman et al. (2004)Fowlpox virus Iowa FWPV 288539 NC 002188 Afonso et al. (2000)
Parapox Bovine papular stomatitis virus BV-AR02 BPSV 134431 NC 005337 Delhon et al. (2004)Orf virus NZ2 ORFV 137820 DQ184476 Mercer et al. (2006)
Unclassified
Crocodilepox virus CRV 190054 NC 008030 Afonso et al. (2006)
Deerpox virus W-1170-84 DPV 170560 AY689437 Afonso et al. (2005)
a Not determined.
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Comparative genomics reported here reveals the similarities and
differences within and without Yatapoxviruses. In particular, the
genetic relationships of TPV with sequenced isolates of the gen-
era Capripoxvirus and Suipoxvirus and an unclassified Deerpox
virus are explored.
2. Materials and methods
2.1. Genomic sequencing
Sequencing was performed essentially as described else-
where (Esposito et al., 2006). Briefly, TPV genomic DNA was
extracted from cells infected with TPV-Kenya (Knight et al.,
1989) and TPV-RoC (Dhar et al., 2004). The genomic DNA
was used as template for production of a set of 14 overlapping
polymerase chain reaction (PCR) amplicons that span virtu-
ally the entire viral genome. Amplicons of 10–12 kbp each
were produced using the Expand High Fidelity PCR System
(Roche Applied Science, Indianapolis, IN, USA). The product
of eight identical PCR mixtures for each amplicon were pooled
and treated with ExoSap-IT (USB Corporation, Cleveland, OH,
USA) to reduce PCR errors in the amplicon templates, which
were used for primer-walking cycle-sequencing reactions. Cycle
sequencing reactions used Applied Biosystems (PE Biosystems,
Foster City, CA, USA) Big-Dye 3.1 dye chemistry and ABI
3730XL DNA sequencers and the sequencing primers (Inte-
grated DNA Technologies, Coralville, IA, USA) were designed
to anneal approximately at every 400 bases across the templates,
which enabled a nine-fold average sequence redundancy. To
verify certain sequences, additional cycle sequencing involved
direct sequencing from the full-length extracted genome DNA.
Chromatogram data was assembled using Seqmerge (Wisconsin
Package Version 10.3, Accelrys Inc., San Diego, CA, USA) and
Phred/Phrap base-calling and assembly software and Consed for
sequence editing (Balbas and Gosset, 2001; Domi and Moss,
2002). ORFs were identified and alignments performed using
MacVector 6.5.3 (Oxford Molecular Ltd.).
2.2. Estimation of nucleotide substitution
TPV-Kenya and TPV-RoC were compared 25,000 bp at a time
by using a base-by-base pairwise comparison matrix contain-
ing 144,565 nucleotide positions. Nucleotide differences were
analyzed for transversions and transitions.
3. Results
Two TPV isolates from infected humans either living (TPV-
Kenya) or traveling (TPV-RoC) through equatorial Africa were
sequenced, which provided an opportunity to investigate the evo-
Fig. 1. ORF differences between TPV-RoC and TPV-Kenya. (A) The 11L gene from TPV-RoC (solid black arrow) is a single ORF. The same region from TPV-Kenya
encodes two ORFs (solid gray arrows). The sequences between the comparable regions are identical except for a single transversion at position 10239 of TPV-RoC.
This change results in a termination codon (* [TAG]) in the predicted transcript of TPV-Kenya instead of the incorporation of a glutamic acid (E [GAG]) as predicted
for TPV-RoC. The single nucleotide change is bolded and italized. The sequence presented represents the minus strand. The predicted amino acid sequences for
TPV-RoC or TPV-Kenya are indicated above or below the corresponding nucleotide sequence. Numbers indicate position with the respective genomes. The single
black lines above or below the solid arrows show the region that is represented by the sequence comparison. (B) ClustalW alignment of the 23.5L ORF from YMTV,
TPV-Kenya and TPV-RoC. Similar amino acids are shaded light grey and identical amino acids are shaded dark grey.
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lutionary diversity of two TPVs that spanned 50 years and were
from two different African countries.
3.1. Genome architecture of TPV
In GenBank there are sequences of TPV-Kenya that represent
approximately 8 kbp of the total genome (GenBank acces-
sion numbers AY253325, AF245394 and AF153912); these
sequences are about 98% identical to cognate sequences in a
reported YLDV genome sequence (Lee et al., 2001). In order
to sequence the two TPV isolates described here, PCR ampli-
con and cycle sequencing primers were designed by using
the reported YLDV sequence. The determined sequences of
TPV-Kenya and TPV-RoC comprised 144,565 and 144,553 bp,
respectively, 96% of which encode for putative ORFs. Both
viruses are 73% A + T-rich, which is consistent with the other
sequenced yatapoxviruses (YLDV 73% A + T and YMTV 70%
A + T) (Brunetti et al., 2003; Lee et al., 2001). By comparison
with the YLDV sequences, the TPV sequences lack the putative
concatemer resolution domain proximal to the hairpin-loop ter-
mini. However, the two TPV isolates were sequenced to within
20 bp of cognate reported YLDV genomic sequences (Lee et al.,
2001).
TPV-Kenya and TPV-RoC encode 156 and 155 distinct
ORFs, respectively (Table 2). All ORFs that were reported
for YLDV are present in both isolates of TPV, with two
exceptions—ORF 11L and ORF 23.5L (Fig. 1). TPV-Kenya 11L
has a premature stop codon at codon 236, which results in a trun-
cated ORF (Fig. 1A). Approximately 80 bp downstream of the
11L stop codon in TPV-Kenya, a putative ORF corresponding
to the second half of the 11L ORF is present and may be tran-
scribed as a distinct gene product. The two ORFs in TPV-Kenya
are denoted 11.1L and 11.2L (Fig. 1A and Table 2). The two pre-
dicted ORFs have been identified previously and were annotated
in GenBank. TPV-Kenya 11.1L was previously labeled TPV
ORFL7R (accession number AAD46181) and TPV ORFL8R
(accession number AAD46182). The ORF 11.2L is identical
to TPV ORFL4R (accession number AAD46179), which indi-
cates that this truncated ORF has been independently identified.
In contrast, the 11L ORF in TPV-RoC is not truncated. The
TPV-RoC 11L-encoded protein is an ankyrin repeat protein
that contains a predicted F-box domain (Fig. 2B) (Mercer et
Fig. 2. Structural analysis of multiple ankyrin repeat-containing proteins. (A) Various homologous ankyrin repeat-containing proteins were identified using the
c-terminal end of the TPV 11L protein as a query sequence. Predicted ankyrin repeats are indicated by the boxes (ANK). Numbers indicate the amino acid length of
the various proteins from various poxviruses, including: TPV-RoC (TPV11L), TPV-Kenya (TPV11.1L and TPV11.2L), LSDV, MYXV (M148R), DPV and VACV
(WR019 and WR186). (B) The C-terminal end of each of the proteins in the top panel is aligned. DPV019 and LSDV145 had an approximately 30 amino acid
stretch, N-terminal to the aligned sequence that did not match and these residues are not included. The bold line underneath the alignment indicates the putative
F-box domain that is complete in all sequences but WR019.
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Table 2
Identification of the predicted open reading frames (ORFs) of TPV-Kenya and TPV-RoC
ORF TPV-Kenya TPV-RoC Predicted structure
or function
DPVa LSDVb VACVc MYXVd YMTVe
Codon aaf Codon aa ORF Identity/
similarity
ORF Identity/
similarity
ORF Identity/
similarity
ORF Identity/
similarity
ORF Identity/
similarity
Start Stop Start Stop
1L 1738 740 333 1738 740 333 DPV007 38/60 LSDV007 33/55 WR010 28/49 1L 71/84
2L 2868 1855 338 2868 1855 338 TNF binding
protein
DPV008 38/53 2L 73/82
3L 3583 2918 222 3583 2918 222 DPV009 42/66 LSDV150 WR039 38/60
4L 4329 3616 238 4329 3616 238 DPV011 35/62 LSDV009 35/56 WR029 33/62 4L 71/83
5L 4840 4373 156 4840 4373 156 LAP/PHD domain LSDV010 45/59 M153R 39/56 5L 64/82
6L 5354 4908 149 5353 4907 149 LSDV001 37/57 WR196 41/63 6L 81/93
7L 6473 5421 351 6471 5419 351 Chemokine
inhibitor
DPV013 49/70 LSDV011 40/66 7L 74/87
8L 7131 6493 213 7129 6491 213 Ankyrin repeat DPV014 32/58 LSDV012 43/65 M149R 28/53 11L 27/53
9L 7848 7171 226 7846 7169 226 Virulence gene
factor
DPV017 39/62 WR031 34/51 M154L 26/46
10L 9021 7873 383 9019 7871 383 SERPIN/Spi3ortholog DPV018 45/61 WR034 29/48 M008.1 31/52
11L 10944 9034 637 Ankyrin repeat DPV019 51/69 WR186 27/45 11L 79/93
11.1L 10160 9036 375 Ankyrin repeat DPV019 51/69 LSDV148 23/45 WR186 27/46 M149R 29/49 11L 79/93
11.2L 10946 10242 235 Ankyrin repeat DPV019 52/73 LSDV145 31/52 WR019 29/47 M148R 23/45 11L 82/94
12L 11232 10969 88 11230 10967 88 IF2-like PKR
inhibitor
DPV020 51/73 LSDV014 47/66 WR034 37/57 12L 75/88
13L 12121 11267 285 12119 11265 285 Monoglyceride
lipase
WR038 50/70 13L 76/87
14L 12554 12147 136 12552 12145 136 IL-18 binding
protein
DPV021 46/68 LSDV015 40/65 14L 55/72
15L 12815 12585 77 12813 12583 77 EGF-like growth
factor
LSDV016 41/55 M010L 36/52
16L 13345 12818 176 13343 12816 176 Mitochondria
anti-apoptotic
factor
DPV022 35/59 LSDV017 30/54 M011L 27/47 16L 64/80
17L 13821 13393 143 13819 13391 143 dUTPase DPV023 62/74 LSDV018 64/76 WR041 58/73 M012L 63/80 17L 86/95
18L 14246 13866 127 14244 13864 127 Pyrin domain DPV024 40/59 M013L 30/55
19L 15846 14281 522 15844 14279 522 Kelch protein DPV025 37/62 LSDV019 34/54 WR042 27/48 M014L 24/57 19L 76/89
20L 16848 15874 325 16846 15872 325 Ribonucleotide
reductase
DPV026 77/89 LSDV020 78/89 WR043 77/87 M015L 75/86 20L 91/95
21L 17133 16879 85 17131 16877 85 DPV027 30/61 LSDV021 38/60 M016L 42/66 21L 65/84
22L 17480 17172 103 17478 17170 103 22L 34/55
23L 17703 17485 73 17701 17483 73
23.5L 17949 17800 50 18005 17892 38 DPV029 59/68 LSDV023 68/85 WR047 43/69 M018L 58/76 23.5L 86/95
24L 18721 18080 214 18719 18078 214 DPV031 56/82 LSDV024 50/73 WR048 52/75 M019L 46/73 24L 84/93
25L 20036 18702 445 20034 18700 445 Serine/threonine
protein kinase
DPV032 77/90 LSDV025 78/90 WR049 72/83 M020L 73/87 25L 90/96
26L 21988 20063 642 21986 20061 642 EEV maturation DPV034 48/69 LSDV027 45/61 WR051 36/56 M021L 41/61 26L 70/86
27L 23133 22024 370 23131 22022 370 Palmitylated EEV
envelope protein
DPV035 72/86 LSDV028 77/87 WR052 58/74 M022L 72/83 27L 90/94
28L 23332 23189 48 23330 23187 48
28.5L 23529 23359 57 23527 23357 57 28.5L 67/84
16
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Table 2 ( Continued )
ORF TPV-Kenya TPV-RoC Predicted structure
or function
DPVa LSDVb VACVc MYXVd YMTVe
Codon aaf Codon aa ORF Identity/
similarity
ORF Identity/
similarity
ORF Identity/
similarity
ORF Identity/
similarity
ORF Identity/
similarity
Start Stop Start Stop
29L 24027 23584 148 24025 23582 148 DPV037 66/80 LSDV029 67/81 WR054 56/73 M024L 52/72 29L 82/92
30L 24738 24094 215 24736 24092 215 DPV038 41/61 LSDV030 38/59 WR055 41/59 M025L 33/55 30L 77/92
31R 24797 25111 105 24795 25109 105 DNA-binding
virion core protein
DPV039 70/86 LSDV031 73/83 WR056 55/75 M026R 70/83 31R 90/95
32L 26523 25114 470 26521 25112 470 Poly(A)
polymerase
DPV040 72/86 LSDV032 72/85 WR057 67/83 M027L 71/84 32L 91/98
33L 28597 26543 685 28595 26541 685 DPV041 50/72 LSDV033 44/66 WR058 40/62 M028L 45/66 33L 72/88
34L 29202 28660 181 29200 28658 181 dsRNA-binding DPV042 45/64 LSDV034 49/69 WR059 38/55 M029L 58/75 34L 68/83
35L 29811 29245 189 29809 29243 189 RNA polymerase
subunit rpo30
DPV043 68/83 LSDV036 69/81 WR060 71/85 M030L 67/82 35L 86/93
36R 29928 30983 352 29926 30981 352 DPV044 35/51 LSDV035 37/56 WR061 25/44 M031R 31/53 36R 74/88
37R 30987 32687 567 30985 32685 567 DPV045 70/85 LSDV037 70/85 WR062 61/81 M032R 63/81 37R 87/95
38R 32710 33513 268 32708 33511 268 DPV046 80/91 LSDV038 79/91 WR064 70/81 M033R 76/87 38R 93/97
39L 36533 33516 1006 36531 33514 1006 DNA polymerase DPV047 70/84 LSDV039 70/85 WR065 69/82 M034R 70/84 39L 86/93
40R 36566 36847 94 36564 36845 94 DPV048 70/88 LSDV040 72/86 WR066 66/80 M035R 66/89 40R 88/97
41L 37236 36850 129 37234 36848 129 LSDV041 54/74 WR067 44/71 41L 74/87
42L 39262 37226 679 39260 37224 679 DPV050 49/69 LSDV042 42/65 WR068 39/61 M036L 41/65
42.5L 39413 39324 30 39411 39322 30 M037L 67/82
43L 40365 39433 311 40363 39431 311 DNA binding core
protein
DPV051 73/87 LSDV043 69/86 WR070 68/83 M038L 69/87 43L 86/96
44L 40590 40369 74 40588 40367 74 DPV052 50/63 LSDV044 49/66 WR071 45/62 M039L 45/68 44L 79/89
45L 41391 40594 266 41389 40592 266 ssDNA-binding
phosphoprotein
DPV053 64/83 LSDV045 61/77 WR072 55/72 M040L 58/81 45L 87/94
46L 41694 41458 79 41692 41456 79 Structural DPV055 78/93 LSDV046 68/81 WR074 46/76 M041L 46/71 46L 86/96
47L 42872 41715 386 42870 41713 386 DPV056 55/78 LSDV047 54/72 WR075 54/74 M042L 50/71 47L 83/93
48L 44158 42872 429 44156 42870 429 Topoisomerase II DPV057 77/90 LSDV048 76/88 WR076 69/85 M043L 73/85 48L 92/97
49R 44164 46191 676 44162 46189 676 Helicase DPV058 62/78 LSDV049 65/80 WR077 58/76 M044R 57/75 49R 84/93
50L 47963 46194 590 47961 46192 590 Metalloprotease DPV059 64/79 LSDV050 60/78 WR078 55/75 M45L 58/75 50L 82/92
51L 48295 47963 111 48293 47961 111 DPV061 55/75 LSDV052 43/66 WR079 44/65 M46L 54/73 51L 73/86
52R 48289 48954 222 48287 48952 222 Transcriptional
elongation factor
DPV060 50/72 LSDV051 49/70 WR080 49/71 M47R 46/66 52R 85/94
53L 49301 48927 125 49299 48925 125 Glutaredoxin DPV062 73/88 LSDV053 76/88 WR081 44/65 M48L 68/85 53L 99/100
54R 49304 50620 439 49302 50618 439 DPV063 53/69 LSDV054 51/70 WR082 44/61 M49R 47/67 54R 76/89
55R 50626 50814 63 50624 50812 63 RNA polymerase
subunit rpo7
DPV064 85/93 LSDV055 85/95 WR083 79/88 M50R 85/93 55R 96/98
56R 50817 51335 173 50815 51333 173 DPV065 55/77 LSDV056 56/73 WR084 46/70 M51R 55/78 56R 80/89
57L 52483 51362 374 52481 51360 374 Virion core protein DPV066 64/79 LSDV057 60/75 WR085 51/68 M52L 55/69 57L 82/91
58R 52513 53292 260 52511 53290 260 Late transcription
factor VLTF-1
DPV067 88/98 LSDV058 87/97 WR086 83/94 M53R 83/94 58R 97/99
59R 53308 54309 334 53306 54307 334 DPV068 64/80 LSDV059 60/77 WR087 50/70 M54R 56/74 59R 80/90
60R 54313 55053 247 54311 55051 247 IMV membrane
protein
DPV069 81/91 LSDV060 81/93 WR088 69/83 M55R 74/92 60R 91/96
61R 55075 55347 91 55073 55345 91 DPV070 45/67 LSDV061 45/70 WR089 30/55 M56R 24/50 61R 71/84
62L 56276 55329 316 56274 55327 316 DPV071 65/83 LSDV062 66/84 WR090 54/74 M57L 60/80 62L 86/95
63R 56301 57047 249 56299 57045 249 Core protein VP8 DPV072 78/87 LSDV063 78/89 WR091 60/82 M58R 76/87 63R 91/95
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64R 57066 57449 128 57064 57447 128 IMV membrane
protein
DPV073 51/75 LSDV064 59/77 WR092 46/67 M59R 52/70 64R 78/90
65R 57406 57882 159 57404 57880 159 Virion protein DPV074 63/81 LSDV065 67/78 WR093 49/69 M60R 59/71 65R 83/92
66R 57882 58430 183 57880 58428 183 Thymidine kinase DPV075 67/78 LSDV066 63/77 WR094 70/78 M61R 66/78 66R 82/90
67R 58481 59014 178 58479 59012 178 Host-range protein DPV076 43/67 LSDV067 42/59 WR021 36/66 M62R 42/64 67R 80/92
68R 59084 60082 333 59081 60079 333 Poly-A
polymerase small
subunit
DPV077 73/89 LSDV068 76/90 WR095 71/87 M65R 73/87 68R 91/95
69R 60000 60554 185 59997 60551 185 RNA polymerase
subunit rpo22
DPV078 76/87 LSDV069 77/90 WR096 74/87 M66R 71/85 69R 92/95
70L 60947 60537 137 60944 60534 137 DPV079 67/81 LSDV070 62/80 WR097 61/80 M67L 66/81 70L 82/94
71R 61038 64892 1285 61035 64889 1285 RNA polymerase
subunit rpo147
DPV080 87/94 LSDV071 84/93 WR098 80/92 M68R 85/94 71R 93/97
72L 65407 64895 171 65404 64892 171 Dual specificity
Ser/Thr and Tyr
phosphatase
DPV081 81/91 LSDV072 75/89 WR099 63/83 M69L 76/88 72L 88/97
73R 65423 65992 190 65420 65989 190 DPV082 69/86 LSDV073 64/83 WR100 62/80 M70R 63/81 73R 84/94
74L 66969 66001 323 66966 65998 323 IMV envelope
protein p35
DPV083 54/74 LSDV074 52/73 WR101 35/61 M71L 50/74 74L 80/91
75L 69366 66973 798 69363 66970 798 RNA polymerase-
associated
RAP94
DPV084 78/89 LSDV075 77/88 WR102 69/84 M72L 75/85 75L 91/97
76R 69525 70064 180 69522 70061 180 Late transcription
factor VLTF-4
DPV085 48/68 LSDV076 43/64 WR103 41/57 M73R 44/65 76R 77/86
77R 70080 71024 315 70077 71021 315 DNA
topoisomerase
DPV086 68/85 LSDV077 69/86 WR104 63/82 M74R 62/82 77R 84/93
78R 71043 71486 148 71040 71483 148 DPV087 51/67 LSDV078 52/69 WR105 39/68 M75R 51/69 78R 80/91
79R 71526 74045 840 71524 74043 840 mRNA capping
enzyme large
subunit
DPV088 71/87 LSDV079 72/86 WR106 68/84 M76R 69/84 79R 88/95
80L 74471 74013 153 74469 74011 153 Virion protein DPV090 41/64 LSDV080 36/59 WR107 48/68 M77L 40/63 80L 74/91
81R 74470 75204 245 74468 75202 245 Virion protein DPV089 41/61 LSDV081 36/61 WR108 38/56 M78R 30/54 81R 67/84
82R 75204 75857 218 75202 75855 218 Uracil DNA
glycosylase
DPV091 76/88 LSDV082 72/87 WR109 69/88 M79R 72/87 82R 82/93
83R 75924 78281 786 75922 78279 786 NTPase DPV092 80/92 LSDV083 78/91 WR110 70/85 M80R 77/90 83R 94/98
84R 78281 80185 635 78279 80183 635 Early
transctription
factor VETFs
DPV093 88/94 LSDV084 88/94 WR111 80/90 M81R 86/93 84R 95/99
85R 80221 80700 160 80219 80698 160 RNA polymerase
subunit rpo18
DPV094 77/92 LSDV085 80/93 WR112 71/85 M82R 77/90 85R 94/98
86R 80748 81383 212 80746 81381 212 mutT motif DPV095 70/84 LSDV086 68/82 WR114 61/77 M84R 58/77 86R 87/95
87R 81383 82147 255 81381 82145 255 mutT motif DPV096 65/81 LSDV087 65/80 WR115 50/70 M85R 59/78 87R 89/96
88L 84038 82146 631 84036 82144 631 Transcription
termination factor
NPH-1
DPV097 75/89 LSDV088 75/88 WR116 70/86 M86L 71/86 88L 92/97
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Table 2 ( Continued )
ORF TPV-Kenya TPV-RoC Predicted structure
or function
DPVa LSDVb VACVc MYXVd YMTVe
Codon aaf Codon aa ORF Identity/
similarity
ORF Identity/
similarity
ORF Identity/
similarity
ORF Identity/
similarity
ORF Identity/
similarity
Start Stop Start Stop
89L 84933 84073 287 84931 84071 287 mRNA capping
enzyme VITF
DPV098 80/91 LSDV089 77/88 WR117 74/89 M87L 77/88 89L 95/98
90L 86620 84965 552 86618 84963 552 Rifampin
resistance protein
DPV099 80/92 LSDV090 80/91 WR118 73/86 M88L 77/90 90L 93/97
91L 87096 86647 150 87094 86645 150 Late transcription
factor VLTF-2
DPV100 64/85 LSDV091 66/84 WR119 63/85 M89L 72/88 91L 87/95
92L 87794 87123 224 87792 87121 224 Late transcription
factor VLTF-3
DPV101 88/95 LSDV092 84/93 WR120 84/95 M90L 86/94 92L 95/98
93L 88018 87794 75 88016 87792 75 Redox virion
protein
DPV102 60/82 LSDV093 64/85 WR121 55/76 M91L 68/82 93L 84/93
94L 90001 88031 657 89999 88029 657 4b core protein DPV103 79/90 LSDV094 73/87 WR122 64/80 M92L 75/87 94L 93/97
95L 90516 90061 152 90514 90059 152 Virion core protein DPV104 44/62 LSDV095 36/55 M93L 31/55 95L 68/82
96R 90556 91059 168 90554 91057 168 RNA polymerase
subunit rpo19
DPV105 64/81 LSDV096 68/85 WR124 62/78 M94R 62/81 96R 87/94
97L 92174 91062 371 92172 91060 371 DPV106 72/89 LSDV097 75/87 WR125 57/78 M95L 69/86 97L 92/98
98L 94333 92201 711 94331 92199 711 Early transcription
factor, VETF1
DPV107 78/90 LSDV098 77/90 WR126 71/86 M96L 76/89 98L 91/96
99R 94386 95255 290 94384 95253 290 Intermediate
transcription factor
VITF-3
DPV108 65/81 LSDV099 67/82 WR127 61/80 M97R 68/83 99R 90/95
100L 95494 95258 79 95492 95256 79 IMV membrane
protein
DPV109 86/91 LSDV100 75/84 WR128 72/81 M98L 78/90 100L 91/94
101L 98203 95498 902 98201 95496 902 Core protein P4a DPV110 69/85 LSDV101 67/82 WR129 54/72 M99L 61/79 101L 92/96
102R 98218 99150 311 98216 99148 311 DPV111 78/89 LSDV102 76/89 WR130 55/75 M100R 75/88 102R 91/96
103L 99672 99166 169 99670 99164 169 Core protein DPV112 58/72 LSDV103 55/70 WR131 46/63 M101L 77/86 103L 77/86
104L 99920 99717 68 99918 99715 68 IMV membrane
protein
DPV113 57/75 LSDV104 56/79 M102L 50/70 104L 83/94
105L 100248 99970 93 100246 99968 93 IMV
phosphoprotein
DPV114 86/94 LSDV105 78/90 WR133 61/77 M103L 73/83 105L 98/94
106L 100426 100268 53 100424 100266 53 IMV membrane
virulence factor
DPV115 84/94 LSDV106 79/88 WR134 66/80 M104L 79/88 106L 100/100
107L 100700 100419 94 100698 100417 94 DPV116 50/69 LSDV107 52/71 WR135 52/67 M105L 51/72 107L 78/88
108L 101829 100687 381 101827 100685 381 IMV protein DPV117 64/81 LSDV108 63/80 WR136 51/70 M106L 55/73 108L 79/87
109L 102418 101846 191 102416 101844 191 IMV membrane
phosphoprotein
DPV118 75/90 LSDV109 61/78 WR137 41/63 M107L 57/73 109L 92/97
110R 102433 103869 479 102431 103867 479 DNA helicase DPV119 62/81 LSDV110 58/76 WR138 58/76 M108R 61/79 110R 85/94
111L 104077 103856 74 104075 103854 74 DPV120 76/90 LSDV111 72/87 WR139 62/77 M109L 81/90 111L 81/94
112L 104410 104081 110 104408 104079 110 Fusion protein DPV122 57/73 LSDV113 57/72 WR140 57/70 M110L 56/74 112L 82/91
113R 104409 105683 425 104407 105681 425 DNA polymerase
processivity factor
DPV121 50/71 LSDV112 51/66 WR141 46/66 M111R 47/66 113R 76/89
114R 105695 106165 157 105693 106163 157 DNA processing DPV123 72/88 LSDV114 67/83 WR142 67/86 M112R 63/83 114R 77/89
115R 106190 107338 383 106188 107336 383 Intermediate
transcription factor
VITF-3
DPV124 60/79 LSDV115 63/78 WR143 60/77 M113R 60/76 115R 84/91
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116R 107343 110837 1165 107341 110835 1165 RNA polymerase
subunit rpo132
DPV125 88/96 LSDV116 89/96 WR144 82/92 M114R 85/94 116R 94/98
117L 111283 110840 148 111281 110838 148 Fusion protein DPV126 39/61 LSDV117 41/64 WR150 43/61 M115L 43/66 117L 41/64
118L 111703 111287 139 111701 111285 139 Viral replication
A28-like
DPV127 70/85 LSDV118 61/78 WR151 54/71 M116L 61/80 118L 78/92
119L 112618 111719 300 112616 111717 300 RNA polymerase
subunit rpo35
DPV128 64/79 LSDV119 66/77 WR152 57/76 M117L 61/77 119L 85/92
120L 112814 112590 75 112812 112588 75 IMV membrane DPV129 69/82 LSDV120 58/77 WR153 54/84 M118L 63/75 120L 90/94
120.5L 112978 112847 44 112976 112845 44 120.5L 69/81
121L 113777 113019 253 113775 113017 253 GTPase; DNA
packaging
DPV131 83/94 LSDV121 83/92 WR155 59/76 M120L 81/92 121L 89/96
122R 113889 114446 186 113887 114444 186 EEV glycoprotein DPV132 44/59 LSDV122 41/55 WR156 33/57 M121R 39/57 122R 66/79
123R 114472 114981 170 114470 114979 170 C-type lectin-like
domain; EEV
glycoprotein
DPV133 64/82 LSDV123 54/75 WR157 48/68 M122R 57/81 123R 79/92
124R 115022 115558 179 115020 115556 179 DPV134 44/66 LSDV124 40/60 WR158 40/57 M123R 41/60 124R 72/84
125R 115597 116451 285 115595 116449 285 DPV135 38/59 LSDV125 37/62 M124R 35/58 125R 81/92
126R 116512 117180 223 116510 117178 223 EEV glycoprotein DPV136 34/49 126R 35/54
127R 117228 118037 270 117226 118035 270 DPV137 39/61 LSDV127 36/58 WR160 27/51 M126R 35/55 127R 70/85
128L 118847 118038 270 118839 118036 268 CD47-like DPV139 32/57 LSDV128 31/52 WR162 23/40 M128L 31/54 128L 66/83
129R 118851 119264 138 118843 119256 138 Myristylprotein DPV138 50/67 WR063 28/45 M129R 36/55 129R 76/88
130L 119813 119256 186 119805 119248 186
131R 119889 120092 68 119881 120084 68 131R 38/65
132R 120123 120368 82 120115 120360 82 DPV141 46/66 LSDV130 45/68 132R 63/80
133L 121408 120380 343 121400 120372 343 3-Beta
hydroxysteroid
dehydrogenase
DPV142 53/69 WR170 43/63
134R 121447 121914 158 121439 121906 156 IL-24-like LSDV005 26/47
135R 121993 127701 1903 121985 127693 1903 VARV B22R-like DPV146 48/65 LSDV134 48/63 M134R 43/59 135R 78/89
136R 127701 128753 351 127693 128745 351 Type-I IFN
receptor
DPV147b 28/51 LSDV135 33/53 WR200 26/44 M135R 23/41
137R 128783 129241 153 128775 129233 153 A52R-family DPV148 37/60 LSDV136 42/68 WR022 22/45 M136R 28/55 137R 72/86
138R 129270 130283 338 129262 130275 338 DVP149 43/61 LSDV137 42/60 WR177 35/59 M137R 32/55 138R 64/80
139R 130362 130931 190 130354 130923 190 A52R-family DPV152 50/69 WR039 26/44 M139R 44/66 139R 68/81
140R 130966 132675 570 130958 132667 570 Kelch-like DPV160 27/47 LSDV151 28/47 WR180 31/56 M140R 43/62
141R 132705 133064 120 132697 133056 120 CD200-like DPV153 44/63 LSDV138 52/69 M141R 38/60 141R 72/82
142R 133101 134027 309 133093 134019 309 Serine/threonine
protein kinase
DPV154 58/76 LSDV139 60/80 WR183 47/64 M142R 56/74 142R 84/92
143R 134063 134764 234 134055 134756 234 Kila-N/RING
finger
DPV155 38/61 LSDV140 38/60 WR208 25/45 M143R 46/64 143R 80/91
144R 134798 135601 268 134790 135593 268 vCCP/EEV host
range
DPV156 42/59 LSDV141 37/56 WR025 33/53 M144R 34/52 144R 64/76
145R 135900 136868 323 135892 136860 323 vCCR8 DPV162 36/60 LSDV011 37/62 145R 66/78
146R 137021 138427 469 137013 138431 473 Ankyrin repeat DPV164 41/63 LSDV147 37/59 WR186 21/41 M149R 34/56 146R 75/86
147R 138465 139937 491 138456 139928 491 Ankyrin repeat DPV164 29/52 LSDV148 35/54 WR186 23/39 M149R 23/58 147R 78/89
20 S.H. Nazarian et al. / Virus Research 129 (2007) 11–25
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al., 2005). A BLAST search of the intact 11L protein revealed
homologues only in YLDV (11L), YMTV (11L), Deerpox virus
(DPV; DPV019) and Vaccinia virus (VACV; VACV WR186).
However, when 11.2L was used as the query sequence, addi-
tional homologues in Myxoma virus (MYXV; M148R), Lumpy
skin disease virus (LSDV; LSDV145) and an additional VACV
protein encoded by VACV WR019 were detected. The proteins
encoded by TPV11L, DPV019, M148R, LSDV145, WR186
and WR019 range from 558 to 675 amino acids and contain
7–14 predicted ankyrin repeats (Fig. 2A). While all proteins
except for VACV WR019 contain the entire predicted F-box
domain (Mercer et al., 2005), there is significant sequence sim-
ilarity outside of the domain (Fig. 2B). It may be that the
sequence, found between the last predicted ankyrin repeat and
the start of the F-box domain, acts as an important functional
determinant of the proteins. The fact that 11L is truncated in
TPV-Kenya suggests that all 14 ankyrin domains are not required
to remain functional. Alternatively, the potential gene products
from ORFs 11.1L and 11.2L might interact and form a functional
complex.
A previously unidentified ORF was annotated between ORFs
23L and 24L of YMTV and denoted 23.5L (Brunetti et al., 2003).
A truncated ortholog was found in YLDV. We find that neither
isolate of TPV contains a full-length copy of this predicted ORF,
as compared with YMTV. However each isolate encodes for a
truncated version of the 23.5L (Fig. 1B). TPV-Kenya encodes a
50 aa ORF that aligns to the carboxy half of YMTV 23.5L and
is 98% identical. In contrast, TPV-RoC encodes a 38 aa ORF
which is 71% identical to the amino terminus of YMTV 23.5L
(Fig. 1B). A transversion at position 17890 changes a tyrosine
(TPV-Kenya) to a stop codon (TPV-RoC) causing premature
termination of TPV-RoC 23.5L. As well, an insertion at position
17994 changes a string of thymines from T5 (TPV-RoC) to T6
(TPV-Kenya) and disrupts the coding from the downstream start
codon on the minus strand.
3.2. Overall nucleotide comparative analysis
Comparison of the two TPV isolates on a nucleotide-by-
nucleotide basis indicates 35 changes across a pairwise sequence
alignment of 144,565 nucleotide positions. Thirty-one of the
changes were within predicted coding regions and could be
divided into 13 transitions, 12 transversions and 6 deletions.
Six transitions cause only synonymous codon changes. The
other seven transitions resulted in non-synonymous substitu-
tions within the coding sequence resulting in a single amino acid
difference between the comparable protein sequences between
the two TPV isolates. Six of these non-synonymous events
resulted in relatively non-conserved changes. In contrast, 11
of the 12 transversions were non-synonymous and 10 of the
11 non-synonymous changes were to non-conserved amino
acids. An A to C transversion at position 10241 changes a
stop codon (TAG) on the minus strand template of 11.1L of
TPV-Kenya to a glutamic acid in TPV-RoC resulting in a full-
length 11L ORF, comparable in length to the other poxvirus
11L orthologs. The 6 deletions represent the absence of one
of four hexanucleotide direct repeats (CATATA) present at the
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Fig. 3. TPV-Kenya genomic map. ORFs are displayed as arrows that also indicate the direction of transcription. The arrows are coloured to indicate a specific
functional category. At either end of the genome is a bolded section that indicates the terminal inverted repeat.
5′ end of ORF 128L in TPV-RoC. The result of this hex-
anucleotide deletion results in a shortened 128L amino acid
sequence in TPV-RoC (MYMYMYNY) compared to TPV-
Kenya (MYMYMYMYNY). The other sequence differences
that distinguish the TPV isolates include two transitions in
non-coding sequences and an insertion in the intergenic region
between ORFs 23L and 23.5L of a thymidine (T) repeat; T8 in
TPV-RoC compared to T7 in TPV-Kenya.
3.3. Conserved DNA sequence near the termini
While examining the intergenic regions of TPV, a predicted
58-codon ORF was found within the TIR, located between the
extreme terminus and 1L/151R. The ORF is transcribed toward
the center of the genome and in the opposite direction of all
ORFs 20 kbp from either end of the DNA (Fig. 3). The ORF
is also present in the YLDV sequence in GenBank but was not
described in the publication, possibly due to the ORF mirror-
image orientation, which might contribute to dsRNA production
(Lee et al., 2001). The comparable region in YMTV was pre-
viously described as a pseudogene (Brunetti et al., 2003). To
determine the likelihood that the ORF encodes a functional pro-
tein, a translated BLAST search (tBLASTx) was used to find
homologous amino acid sequences. Several poxviruses, includ-
ing YLDV, YMTV, LSDV and DPV, have sequences that show
significant homology to the TPV query sequence; however, the
nucleic acid sequences in YMTV, LSDV and DPV lacked a start
codon. Therefore, the cognate sequences appear to represent
either a pseudogene or a terminal DNA sequence conserved
across genera. The region of nucleotide conservation consists
of a 300 nucleotide segment that surrounds the predicted 58-
codon ORF. The TIR regions of all chordopoxviruses were
compared for similarity to these conserved sequences. The 300
Table 3
TIR conserved sequence positions in various poxvirus species
Virus Left end Right end
Start End Start End
TPV-Kenya 400 714 144164 143850
TPV-RoC 400 714 144154 143840
YLDV 418 732 144158 143844
YMTV 437 751 134285 133971
GTPV 1018 1329 148582 148271
LSDV 1286 1592 149488 149182
SHPV 1225 1530 148833 148528
SWPV 1062 1381 145393 145074
DPV 4756 5070 165805 165491
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nucleotide conserved sequence was found in Swinepox virus
(SWPV) and overlapped with a hypothetical gene (designated
002) in SWPV, DPV and Capripoxviruses (Table 3). While this
sequence exhibits homology across genera, the highest identities
were found between members within a particular genus (Fig. 4).
A highly conserved sequence, present in the TIR region of
orthopoxviruses, has been described previously (Shchelkunov et
al., 1998). However, the sequence appears to be distinct from the
300-bpYatapoxvirus sequences and their cognates (Fig. 4). Since
new sequence information has become available from the time
that this DNA region was last compared and reported (Baroudy
et al., 1982; Shchelkunov et al., 1998), selected orthopoxvirus
sequences from CPXV, VACV, VARV, HSPV, TATV, ETCV,
MPXV, CMLV and RCNV (acronyms described in Table 1;
data not shown) were aligned and compared. Interestingly,
CMLV lacks this entire sequence and RCNV encodes for only
137 nucleotides of the ∼300-bp conserved sequences. As pre-
viously described, these orthopoxvirus nucleotide sequences
are highly homologous, sharing 87–100% sequence identity
((Shchelkunov et al., 1998) and data not shown).
3.4. Identification of two conserved poxvirus gene families
Two TPV intergenic regions contained potential ORFs below
the commonly used codon limit of 50. The ORFs are located
between 27L and 28.5L, and 42L and 43L; they were desig-
nated 28L and 42.5L, respectively (Table 2). To determine if
these ORFs likely encode functional proteins, tBLASTx was
used to find homologous sequences. However, due to the small
Fig. 4. Identity matrix of a conserved sequence found in the TIR of vari-
ous poxvirus species. An approximately 300 bp region within the TIR of the
poxviruses listed was aligned using ClustalW and percent identity was deter-
mined. Poxviruses are listed in order of relatedness for this particular sequence.
size of these ORFs, BLAST searches were unable to detect any
homologous sequences and thus the search for homologues was
performed manually.
The ORF 28L is present in both TPV and YLDV; the predicted
ORF encodes for a potential protein of 48 aa. The region between
orthologues of 27L and 28.5L of the genomes of species of chor-
dopoxviruses currently available were examined. Orthologues
were identified in all orthopoxviruses, parapoxviruses, SWPV,
and the unclassified poxviruses DPV and Crocodilepox virus
(CRV) (Fig. 5a). However, the closely related capripoxviruses
lacked a homologous gene in this region. Members of the genera
Avipoxvirus, Leporipoxvirus and Molluscum contagiosum virus
also lacked the sequence (Table 4).
The ORF 42.5L is predicted to encode a 30 amino acid pro-
tein. A search of all poxvirus genomes for orthologues showed
that ORF 42.5L is highly conserved among the Chordopoxviri-
nae and orthologues in all vertebrate poxviruses currently
Fig. 5. Alignments of the predicted 28L and 42.5L gene families. (a) Orthologs of TPV 28L are aligned and include YLDV, DPV, SWPV, ECTV (EVM037), VACV
(WR053), ORFV, CRV. (b) Orthologs of TPV 42.5L are aligned and include YLDV, YMTV, LSDV, DPV, MYXV (M37L), VARV, VACV (WR220), as annotated at
www.poxvirus.org.
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Table 4
Members of two new poxvirus gene families
Genus Virus 28L gene family 42.5L gene family
Designation Start Stop Designation Start Stop
Yatapox
TPV-RoC 28L 23330 23187 42.5L 39411 39322
TPV-Kenya 28L 23332 23189 42.5L 39413 39324
YLDV 28L 23342 23199 42.5L 39425 39336
YMTV NPa 42.5L 33938 33852
Capripox
GTPV NP 038.5 37590 37504
SHPV NP 038.5 37805 37719
LSDV NP 042.5 38189 38103
Suipox SWPV 026 19915 19724 038.5 34712 34620
Leporipox MYXV NP 37L 39385 39290SHFV NP 37L 39399 39316
Molluscipox MOCV NP 043.5L 64055 63933
Orthopox
ECTV 037 50964 50749 053.5 68659 68555
MPXV C20L 42461 42240 I0.5L 59903 59799
CPXV 062 58869 58648 079.5 76579 76475
VARV 041 33516 33295 058.5 51129 51025
HSPV 054 53482 53261 070.5 71114 71010
TATV 054 42022 41807 072.5 59706 59602
CMPV 49L 43284 43063 66.5L 60901 60797
VACV 053 42188 41967 220b 59851 59744
Avipox FWPV NP 090.5 90681 90782CNPV NP 117.5 120153 120254
Parapox ORFV 012.5
b 11760 11578 029.5 32396 32244
BPSV 011.5b 12820 12650 028.5 33354 33214
Unclassified
CRV 044 58267 58025 064.5 86842 86762
DPV 036 32435 32226 050.5 49191 49060
a Not present.
b Annotated at www.poxvirus.org/.
sequenced were found (Fig. 5b). The nucleotide sequence has
previously only been reported as a putative ORF of 32 codons
for sequenced leporipoxviruses (Cameron et al., 1999; Willer
et al., 1999). Additionally, an orthologue, VACV ORF WR220,
has been annotated in sequences at http://www.poxvirus.org/
(Table 4).
4. Discussion
The virtually complete genome sequences were determined
for two isolates of TPV recovered from clinical cases that
occurred about 50 years apart. Annotation of the determined
sequences revealed a single ORF difference between the two
genomes. The ORF 11L is truncated in TPV-Kenya compared
to TPV-RoC, which suggests that even the small genetic vari-
ability present between the two genomes has possibly resulted
in changes to the proteome. A TPV nucleotide sequence is con-
served in the TIR region of several poxviruses closely related
to the yatapoxviruses. An analogous but distinct DNA sequence
located in the correlate region of the genome is also present in the
orthopoxviruses. Finally, two novel gene families are proposed
following identification using comparative genomics.
One of the difficulties that arise when limited sequences are
available for comparison is that, ORFs that do not meet the
standard search parameters can be difficult to assign. Many
poxvirus ORFs are quite small and it is unlikely that they will
achieve a significant match using BLAST. Selected available
sequences from chordopoxviruses were used to determine sig-
nificantly conserved sequences in TPV. One approach was to
compare a tentatively designated ORF and examine areas of sev-
eral poxviruses that contained highly conserved ORFs flanking
this region.
Using this method, two previously unidentified gene families,
28L and 42.5L, which are clearly present in members of sev-
eral other poxvirus genera, were identified. The region between
ORFs 27L and 28.5L was previously assigned to a large but
overlapping ORF (28R) that was identified in YLDV (Lee et
al., 2001); therefore ORF 28L was not originally identified as a
putative gene. However, the evidence that orthologs of 28L are
encoded by a variety of poxviruses suggests that 28L encodes
a protein product (Table 4). Conversely, 42.5L had previously
only been identified in the leporipoxviruses but this ortholog
is highly conserved among the Chordopoxvirinae. Due to its
extremely small size (30–44 codons), it is unlikely to have been
considered an ORF previously. On close inspection, however,
42.5L has a conserved early and late promoter (data not shown;
www.poxvirus.org/) and the putative amino acid sequence shares
62–77% identity with orthologs among other chordopoxviruses.
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These properties should be sufficient to designate 42.5L as a
putative ORF. Other related predictive methods, such as analyz-
ing purine skew of the ORFs (Da Silva and Upton, 2005), were
not used since both of these ORFs had clear orthologues in other
poxviruses.
In addition to identifying new putative ORFs, a conserved
DNA sequence in the TIR of several genera of poxviruses was
described. An analogous sequence that exhibited a similar orga-
nization pattern, but did not show significant homology, has been
identified previously in the orthopoxviruses. A possible role in
DNA replication for the orthopoxvirus conserved sequence in
the TIR region has been proposed (Shchelkunov et al., 1998),
but since there is considerable divergence of the sequence across
genera, a precise mechanism is unclear and may be structural
rather than sequence-specific. Structural elements such as Hol-
liday Junctions and cruciform structures have been shown to be
important for resolution of concatenated DNA into unit length
DNA molecules (Palaniyar et al., 1999). This sequence may
fulfill its function in a similar way, relying on a structural motif.
If the conserved sequence does, in fact, play a role in DNA
replication, then a sequence that performs a similar function
must be present in all poxviruses. Therefore, an attempt to define
this sequence in other poxvirus species was made. It is possible
to find sequences in other poxvirus TIRs that share some homol-
ogy to the conserved sequence; however, without more sequence
information from viral members within genera it is difficult to
clearly define since there is a lack of sequence information for
viral members within other poxvirus genera, including two gen-
era composed of only a single member each (Suipoxvirus and
Molluscipoxvirus).
Through a comparative genomics approach, we have iden-
tified important additional features of yatapoxviruses noted by
prior sequencing of YMTV and YLDV. The results presented
indicate a relatively slow evolutionary rate, which suggests a
relatively stable, confined evolutionary niche. From this stand-
point, the primate host-range of TPV and YLDV in the central
region of the rainforest of Africa appears to have remained
the same, at least for 50 years, despite extensive ecological
changes, particularly urbanization of forested areas. There have
been suggestions that an insect vector might be involved in Yat-
apoxvirus transmission because TPV and YLDV infection are
localized to one or two lesions and not systemic like smallpox
(Damon, 2007). Maintaining a lifecycle that includes a poten-
tial non-human primate reservoir, an insect reservoir, as well
as a human reservoir suggests that a constant genetic selective
pressure might be maintained on the TPV and YLDV genome,
which would lower the likelihood of sequence divergence. How-
ever, this may not explain the lack of nucleotide changes in the
third bp position and it is unlikely that the DNA polymerase
encoded by Yatapoxviruses has a high enough fidelity to explain
this phenomenon. The codon bias present in many Yatapoxvirus
genes represent the most rarely used codons in mammalian cells
(Barrett et al., 2006). An alternative explanation to explain the
third position conservation is that this codon bias is required for
efficient gene expression in a variety of distinct host species.
In contrast, a poxvirus that is able to infect several different
hosts, e.g. Cowpox virus, which appears to be parental to the
orthopoxviruses, has a sequence that is more amenable to chang-
ing with different hosts.
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